View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 14, 2021
2 min read
Save

CDC advisory group says it needs more info on J&J vaccine

CDC advisory group says it needs more info on J&J vaccine

A CDC advisory committee said Wednesday that it needs more information before it can decide whether to alter its recommendation for Johnson & Johnson’s COVID-19 vaccine.

SPONSORED CONTENT
April 14, 2021
2 min read
Save

Traditional definition underestimates burden of health care-associated flu

Traditional definition underestimates burden of health care-associated flu

Using a traditional definition of health care-associated influenza missed more than 80% of possible cases among patients admitted to acute-care hospitals during seven influenza seasons, researchers reported at the SHEA Spring Conference.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
April 14, 2021
1 min read
Save

Leaving middle seat vacant on planes can reduce SARS-CoV-2 exposure, study shows

Leaving middle seat vacant on planes can reduce SARS-CoV-2 exposure, study shows

Leaving the middle seat vacant on airplanes reduced exposure to SARS-CoV-2 by up to 57% in a laboratory-based modeling study, according to results published in MMWR.

SPONSORED CONTENT
April 14, 2021
4 min read
Save

Q&A: What is herd immunity and what will happen to SARS-CoV-2 if we reach it?

Q&A: What is herd immunity and what will happen to SARS-CoV-2 if we reach it?

In recent comments regarding COVID-19, National Institute of Allergy and Infectious Diseases Director and chief presidential medical advisor Anthony S. Fauci, MD, referred to the concept of herd immunity as “an elusive number.”

SPONSORED CONTENT
April 13, 2021
3 min read
Save

Study provides ‘greater insight’ into MIS-C

Study provides ‘greater insight’ into MIS-C

Two peaks of multisystem inflammatory syndrome in children — the rare but severe condition associated with SARS-CoV-2 infection — occurred 2 to 5 weeks after peaks of COVID-19 in United States, experts reported in JAMA Pediatrics.

SPONSORED CONTENT
April 13, 2021
1 min read
Save

CDC, FDA recommend pausing rollout of J&J vaccine over six blood clot cases

CDC, FDA recommend pausing rollout of J&J vaccine over six blood clot cases

Federal health officials recommended Tuesday that the U.S. “pause” the rollout of Johnson & Johnson’s COVID-19 vaccine so experts can review six reported cases of a rare but severe type of blood clot in people who have received the vaccine.

SPONSORED CONTENT
April 12, 2021
2 min read
Save

Subcutaneous injection of antibody cocktail reduces risk for symptomatic SARS-CoV-2

Subcutaneous injection of antibody cocktail reduces risk for symptomatic SARS-CoV-2

One subcutaneous injection of REGEN-COV — a combination of two monoclonal antibodies — reduced the risk for symptomatic SARS-CoV-2 infection by more than 80% among household contacts of infected individuals, Regeneron said.

SPONSORED CONTENT
April 12, 2021
2 min read
Save

Racial, ethnic disparities persist for COVID-19 hospitalizations, ED visits

Racial, ethnic disparities persist for COVID-19 hospitalizations, ED visits

Racial and ethnic disparities for hospitalizations and ED visits related to COVID-19 persisted through the end of last year, according to two new MMWR reports.

SPONSORED CONTENT
April 12, 2021
2 min read
Save

Dapagliflozin fails to prevent organ damage, death in adults hospitalized with COVID-19

Dapagliflozin fails to prevent organ damage, death in adults hospitalized with COVID-19

Top-line data from the phase 3 DARE-19 trial show that the SGLT2 inhibitor dapagliflozin failed to prevent organ dysfunction and all-cause mortality among hospitalized patients with COVID-19 at risk for developing serious complications.

SPONSORED CONTENT
April 09, 2021
1 min read
Save

FDA says HCP can transition away from reusing disposable respirators

FDA says HCP can transition away from reusing disposable respirators

The FDA recommended that facilities begin to move away from “crisis capacity conservation measures” implemented during the COVID-19 pandemic, such as reusing decontaminated respirators.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails